Impaired DNA harm response pathways might create vulnerabilities of most cancers cells that may be exploited therapeutically. One such selective vulnerability is the sensitivity of BRCA1- or BRCA2-defective tumors (therefore faulty in DNA restore by homologous recombination, HR) to inhibitors Read more…
Comparability of the results of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal girls with Genitourinary Syndrome of Menopause (GSM) Goal: To match the results of a 12-week course of 5percentPueraria mirifica gel and placebo gel on the prevalence of Read more…